| NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
| NCT01340235 | Epidermolysis Bullosa | Drug: Oral erythromycin | Centre Hospitalier Universitaire de Nice | Phase 3 | 2011-06-01 | 2011-10-13 |
| NCT02175914 | FAP-Familial Adenomatous Polyposis | Drug: Erythromycin | michal roll|Tel-Aviv Sourasky Medical Center | Phase 4 | 2014-06-01 | 2014-06-25 |
| NCT02354560 | FAP-Familial Adenomatous Polyposis | Drug: Erythromycin | michal roll|Tel-Aviv Sourasky Medical Center | Phase 4 | 2015-06-01 | 2015-01-29 |
| NCT01556334 | Preterm Premature Ruptured Membranes | Drug: Azithromycin|Drug: Erythromycin | Indiana University | Phase 3 | 2010-04-01 | 2014-03-04 |
| NCT01323582 | Gastroparesis | Drug: Erythromycin|Drug: Azithromycin | University of Florida|Metabolic Solutions Inc. | Phase 2 | 2009-02-01 | 2014-12-04 |
| NCT01060267 | Variceal Bleeding | Drug: Erythromycin|Drug: Placebo | King Abdulaziz Medical City | | 2007-01-01 | 2010-02-01 |
| NCT01478256 | Blepharitis | Drug: Erythromycin|Drug: Besifloxocin | John, George, M.D.|Bausch & Lomb Incorporated | Phase 4 | 2011-08-01 | 2013-11-20 |
| NCT01716572 | Gastrointestinal Hemorrhage|Hematemesis | Drug: Erythromycin|Procedure: gastric lavage | Hospital Universitari de Bellvitge|Ministerio de Sanidad, Servicios Sociales e Igualdad | Phase 3 | 2012-02-01 | 2015-10-07 |
| NCT02005029 | Parkinson's Disease|Levodopa | Drug: Erythromycin|Drug: placebo | Virginia Commonwealth University | | 2013-04-01 | 2016-12-15 |
| NCT00318201 | Healthy | Drug: Erythromycin|Drug: Diltiazem | Indiana University School of Medicine|Indiana University | Phase 4 | 2006-04-01 | 2012-04-05 |
| NCT01274754 | Functional Disturbances Following Cardiac Surgery | AHEPA University Hospital|University of Thessaly | | 2008-11-01 | 2014-12-01 |
| NCT01117376 | Gastroparesis | Drug: Erythromycin|Drug: Methylnaltrexone | Shiraz University of Medical Sciences | Phase 2 | 2010-05-01 | 2011-03-30 |
| NCT01589614 | Healthy | Drug: PH-797804|Drug: PH-797804 + erythromycin | Pfizer | Phase 1 | 2012-06-01 | 2012-08-16 |
| NCT01659619 | Subtotal Gastrectomy|Stomach Cancer | Drug: Erythromycin | The Catholic University of Korea | Phase 2 | 2012-04-01 | 2013-02-20 |
| NCT03060473 | Preterm Premature Rupture of Membranes (PPROM) | Drug: Azithromycin|Drug: Erythromycin|Drug: Ampicillin|Drug: Amoxicillin | The University of Texas Medical Branch, Galveston | Phase 3 | 2017-03-01 | 2017-02-17 |
| NCT00304187 | Bulimia Nervosa|Eating Disorders | Drug: Erythromycin|Drug: Placebo | New York State Psychiatric Institute|National Institute of Mental Health (NIMH) | Phase 2 | 2004-09-01 | 2013-06-21 |
| NCT01342198 | Healthy | Drug: Pregabalin controlled release, 330 mg|Drug: Pregabalin controlled release, 330 mg|Drug: erythromycin | Pfizer | Phase 1 | 2011-06-01 | 2011-07-27 |
| NCT01379183 | Healthy | Drug: Erythromycin|Drug: Placebo|Procedure: Magnetic Resonance Imaging|Other: Barium Sulfate Solution | Mayo Clinic|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2|Phase 3 | 2011-06-01 | 2016-02-19 |
| NCT01431248 | Preterm Premature Rupture of Membranes | University of Oklahoma|Indiana University School of Medicine | | 2011-09-01 | 2013-01-15 |
| NCT01825473 | Gastroesophageal Reflux|Apnea|Bradycardia | Drug: Erythromycin|Device: Multi-channel intra-luminal impedance (MII) pH monitoring|Drug: Placebo (D5W) | University of Virginia | | 2012-09-01 | 2013-04-02 |
